Kymera Therapeutics (KYMR) Non-Current Deffered Revenue (2019 - 2025)
Kymera Therapeutics (KYMR) posted Non-Current Deffered Revenue of $11.44 million for Q4 2025, down 18.0% from the prior quarter.
Analysis
Kymera Therapeutics (KYMR) Non-Current Deffered Revenue (2019 - 2025) Analysis & Trends
Since Q4 2019, Kymera Therapeutics has reported Non-Current Deffered Revenue for 19 quarters.
- Annual Non-Current Deffered Revenue shows a five-year compound annual growth rate of -31.9% (FY2020 to FY2025).
- In prior years, Kymera Therapeutics' Non-Current Deffered Revenue was $16.77 million in FY2023 (-40.1%), $28 million in FY2022 (-28.7%) and $39.3 million in FY2021 (-49.5%).
- The Q4 2025 figure stands as the lowest quarterly Non-Current Deffered Revenue since Q2 2024.
- Over the past five years, the year-over-year decline in Non-Current Deffered Revenue ranged from 4.4% (Q1 2024) to 84.4% (Q2 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Kymera Therapeutics | 8.89 Bn | 6.19 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 11.44 Mn |
| Sep 30, 2025 | 13.96 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Mar 31, 2024 | 23.78 Mn |
| Dec 31, 2023 | 16.77 Mn |
| Sep 30, 2023 | 16.42 Mn |
| Jun 30, 2023 | 20.42 Mn |
| Mar 31, 2023 | 24.87 Mn |
| Dec 31, 2022 | 28.00 Mn |
| Sep 30, 2022 | 21.09 Mn |
| Jun 30, 2022 | 24.07 Mn |
| Mar 31, 2022 | 31.82 Mn |
| Dec 31, 2021 | 39.30 Mn |
| Sep 30, 2021 | 49.94 Mn |
| Jun 30, 2021 | 52.67 Mn |
| Mar 31, 2021 | 64.65 Mn |
| Dec 31, 2020 | 77.84 Mn |
| Sep 30, 2020 | 90.31 Mn |
| Dec 31, 2019 | 29.64 Mn |
API Access
Kymera Therapeutics Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=KYMR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();